Oncotarget

Research Papers:

Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells

Yusuke Inagaki, Eiji Kubota _, Yoshinori Mori, Mineyoshi Aoyama, Hiromi Kataoka, Randal N. Johnston and Takashi Joh

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:115632-115646. https://doi.org/10.18632/oncotarget.23361

Metrics: PDF 478 views  |   HTML 1604 views  |   ?  


Abstract

Yusuke Inagaki1, Eiji Kubota1, Yoshinori Mori2, Mineyoshi Aoyama3, Hiromi Kataoka1, Randal N. Johnston4 and Takashi Joh1

1Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Mizuho-Ku, Nagoya, Japan

2Department of Gastroenterology, Nagoya City West Medical Center, Kita-Ku, Nagoya, Japan

3Department of Pathobiology, Nagoya City University Graduate School of Pharmaceutical Sciences, Mizuho-Ku, Nagoya, Japan

4Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada

Correspondence to:

Eiji Kubota, email: ekubota@med.nagoya-cu.ac.jp

Keywords: reovirus; gastrointestinal stromal tumor (GIST); imatinib; fas; apoptosis

Received: August 09, 2017     Accepted: December 03, 2017     Published: December 18, 2017

ABSTRACT

Imatinib, a multitargeted receptor tyrosine kinase inhibitor, is used as the standard initial therapy against inoperable gastrointestinal stromal tumor (GIST). However, GIST can acquire resistance to imatinib within several years of therapy. The development of oncolytic reovirus as an anticancer agent has expanded to many clinical trials for various tumors. Here, we investigated whether reovirus has antitumor activity against GIST cells in the setting of imatinib sensitivity in vitro and in vivo. Cell proliferation and apoptosis assays were performed using a human GIST cell line, GIST-T1, and imatinib-resistant GIST (GIST-IR) cells that we established. The molecular pathways responsible for cell damage by reovirus were explored using PCR-arrays and Western blots. Reovirus significantly induced apoptotic cell death in GIST-T1 and GIST-IR cells in vitro, despite differences in the activation of receptor tyrosine kinase pathways between GIST-T1 and GIST-IR. Molecular assays indicated the possibility that reovirus induces apoptotic cell death via Fas signaling. Furthermore, in vivo mouse tumor xenograft models demonstrated a significant anti-tumor effect of reovirus on both GIST-T1 and GIST-IR cells. Our results demonstrate the therapeutic potential of reovirus against GIST.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23361